Related Experiment Videos
Treatment of infective endocarditis with granulocyte colony-stimulating factor
Y Hanazono1, K Miyazono, H Tsuchimochi
1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Insights
Granulocyte colony-stimulating factor (G-CSF) effectively treated intractable infective endocarditis in a patient. G-CSF normalized inflammatory markers and increased white blood cell counts without side effects, suggesting its potential for antibiotic-resistant infections.
Area of Science:
- Hematology
- Immunology
- Infectious Diseases
Background:
- Granulocyte colony-stimulating factor (G-CSF) is a key regulator of neutrophil production and function.
- Infective endocarditis is a serious infection often requiring prolonged antibiotic therapy.
- Intractable cases pose significant treatment challenges.
Observation:
- A patient with intractable infective endocarditis was treated with G-CSF.
- The study monitored white blood cell count and inflammatory markers (C-reactive protein, erythrocyte sedimentation rate).
Findings:
- G-CSF administration resulted in a 3-fold increase in white blood cell count.
- Inflammatory markers (C-reactive protein and erythrocyte sedimentation rate) normalized completely.
- No adverse side effects were observed during G-CSF treatment.
Implications:
- This is the first report on G-CSF use for infective endocarditis.
- G-CSF may be a viable therapeutic option for intractable infections unresponsive to antibiotics alone.
- Further research is warranted to explore G-CSF's role in managing severe infections.
Abstract:
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein hormone which stimulates the proliferation and differentiation of a subset of granulocyte precursors and enhances some functional activities of mature neutrophils. We tested the effects of G-CSF on a patient with intractable infective endocarditis. The white blood cell count was increased 3-fold and the inflammatory reactions such as C-reactive protein and erythrocyte sedimentation rate were completely normalized without any side effects. This is the first report describing the use of G-CSF for infective endocarditis. Administration of G-CSF might be suitable for treating intractable infections which cannot be controlled by antibiotics alone.